Panama · Medical and donor conditions

Clinical consent-review desk with a blank document and microscope behind a glass partition; editorial illustration, not a real clinic.
Editorial illustration only; it does not depict a specific clinic or establish regulatory approval.

Panama surrogacy: which medical and donor requirements are law?

Short answer

The sources do not establish a comprehensive, current Panamanian statute setting a complete medical eligibility checklist for a gestational carrier or a full donor-screening code for sperm and egg donation in a surrogacy programme. This is a limit of the evidence located, not proof that no other rule, licence condition or later measure exists.

Some binding rules do apply. Panamanian law protects a woman’s consent to assisted reproduction; general patient-information and informed-consent rules apply; the Family Code links the presumption of maternity to proof of childbirth and the child’s identity; and the Ministry of Health publishes a procedure for authorising import of human semen. These rules answer different questions. None, by itself, proves that a clinic is authorised to conduct a surrogacy programme or that a particular carrier or donor meets every applicable requirement.

Before treatment, require the clinic to separate each claimed legal requirement from its own clinical protocol, identify the exact legal instrument and article, and explain how it applies to the intended procedure and participants.

What the sources establish—and what they do not

Primary sources include the Family Code; the 2010 consolidated Penal Code text and the later CENDOJ consolidation updated through December 2020, together with CENDOJ’s official index of subsequent Penal Code amendments; Law 68/2003 and Executive Decree 1458/2012 on patient rights; Executive Decree 179/2018 on research involving human tissues and cells; and Panama Digital’s human-semen import page. The 2018 decree contains a narrow embryo rule pending regulation of assisted reproduction; it is not a complete surrogacy code.

Secondary sources—a Panamanian judicial-journal article and a 2025 academic essay—also describe a legislative gap. They are not law and cannot establish the status of every current rule. The official materials do not provide a complete statutory list for carrier age, prior births, BMI, psychological assessment, donor age, infection/genetic tests, storage or donor-child limits. Check current Ministry rules and the Official Gazette before relying on this gap.

Rule-versus-policy matrix

Use this matrix as a verification map, not as a declaration that unlocated rules cannot exist.

Issue What the law shows Practical check
Carrier eligibility No comprehensive statutory criteria verified in the sources. Obtain the clinic’s written criteria and an exact current legal citation for any rule described as mandatory.
Donor age, tests, quarantine, donor limits, anonymity and compensation No comprehensive Panamanian surrogacy-specific code was verified for all these points. Request a dated protocol; do not assume a foreign rule automatically applies.
Informed consent General patient-rights and consent rules apply; Penal Code art. 146 addresses assisted reproduction without the woman’s consent. Obtain separate, understandable consent forms and copies.
Import of human semen Panama Digital lists a Ministry of Health authorisation service and a physician’s signed/stamped letter. Confirm current import steps before shipment; this does not certify donor eligibility.
Embryo use/destruction Executive Decree No. 179 art. 9 contains a narrow rule on destroying an embryo solely to use its cells until ART is regulated. Do not treat it as a complete surrogacy or embryo-law code.
Maternity/parentage Family Code art. 243 presumes maternity when childbirth and the child’s identity are duly proved. Assess parentage separately; clinical consent does not guarantee registration.

Gestational carrier: clinical eligibility

Do not assume that common clinical criteria are statutory Panamanian thresholds. The sources did not verify a binding national list specifying, for example, a carrier’s maximum age, a required previous live birth, BMI range, number of permitted embryo transfers or a mandatory psychological-assessment format specifically for surrogacy. A clinic may apply criteria based on medical judgment, safety protocols, insurer conditions or internal policy. Those criteria can matter, but the clinic should not label them “required by Panamanian law” without a precise, current citation.

Request the written assessment pathway: medical/obstetric history, examination and uterine assessment, infection tests and timing, medication and pregnancy-risk review, mental-health support, independent consent without pressure, and follow-up during and after pregnancy. These are prudent risk questions, not a claim that each item is separately codified in Panamanian surrogacy law. Ask what excludes treatment, who reviews borderline results and whether reports are available to the person concerned.

Gamete donors and laboratory safeguards

The materials verified do not establish a comprehensive Panamanian surrogacy-specific code fixing donor age limits, a mandatory panel of infectious or genetic tests, quarantine or repeat-testing periods, a maximum number of families or children per donor, anonymity and identity-disclosure rules, or permitted compensation. Do not import a threshold from Spain, the United States or another country merely because a clinic or sperm bank refers to it. A foreign standard may be part of a clinic’s protocol or contract; its legal effect in Panama needs a separate explanation.

Before accepting donor gametes, request the dated screening protocol; tests and timing; handling of positive, inconclusive or outdated results; source-bank and traceability records; identity and medical-update records; and future information-access rules. Confirm whether the material is local or imported, who obtains import authorisation and what happens if documents are missing. A donor profile or marketing statement does not prove laboratory compliance.

Consent: binding rules that matter

Law 68 of 20 November 2003 and its implementing Executive Decree No. 1458 of 6 November 2012 establish general patient rights concerning information and free, informed decisions. The decree’s consent provisions address the procedure, expected benefits, risks and complications, alternatives, the opportunity to ask questions and the possibility of revoking consent. Where required by the applicable framework, consent must be specific to the proposed intervention; a broad programme form should not be assumed to answer every separate decision about stimulation, egg retrieval, embryo creation, transfer, storage or use of material.

Article 146 of the Penal Code provides criminal penalties for performing assisted reproduction in a woman without her consent. The consolidated text located states imprisonment from two to six years. This is a rule against non-consensual treatment; it does not prescribe every donor-screening test or resolve parentage. Obtain forms in a language the person understands, allow time for independent advice, and confirm consent is voluntary and can be revisited in legally relevant circumstances. A signature does not replace a genuine explanation or the consent of each person whose consent is required. The official CENDOJ consolidated Penal Code updated through December 2020 also contains the same wording for Articles 146–147 and confirms the stated two-to-six-year penalty for Article 146. A check of the official CENDOJ index of subsequent amendments available on 23 October 2026 did not identify a listed later amendment to either article. This is not a certified, exhaustive audit of all current law or its interpretation; before relying on these provisions, ask Panamanian counsel to confirm the operative law for the proposed facts.

Specific restrictions must not be overstated

Article 147 of the Penal Code text located criminalises fertilising human ova for a purpose other than procreation. Apply its wording to the conduct and facts it covers; it is not, on its face, a complete rule permitting or prohibiting every surrogacy arrangement, donor practice or embryo-storage decision. Article 9 of Executive Decree No. 179 of 8 June 2018 states that, until assisted reproduction is regulated by the competent health authorities, an embryo may not be destroyed solely to use its cells. That provision appears in a decree on research with human tissues and cells and has a specific subject and purpose. Whether later measures have changed the present operation of Article 9 has not been confirmed.

Neither provision should be paraphrased as “surrogacy is illegal”, “all embryo research is banned” or “the clinic can do anything not expressly prohibited”. The legal treatment of creating, storing, transferring, donating, discarding or researching embryos may depend on the exact act, applicable health rules and current legal developments. Have Panamanian counsel check the operative text and later amendments before a treatment plan depends on either provision.

Importing human semen is a separate administrative issue

Panama Digital, identifying the Ministry of Health’s Directorate General of Health, lists “Authorisation for the Introduction of Human Semen Biological Material”. The page says the application is handled confidentially by a qualified specialist physician and identifies a letter to the Directorate General of Health, on letterhead and signed and stamped by the physician responsible for the procedure, as the required item. It gives an approximate processing time of two days.

Treat this as the published description of a specific administrative service, not a guarantee of current processing time or an exhaustive import checklist. Confirm live requirements with the Directorate before shipment, including whether the sample, source country, transport route and documents fall within the service. The page concerns human semen; do not assume it automatically governs imported eggs or embryos. Import authorisation does not itself establish that a donor meets a clinical protocol or that a surrogacy arrangement is legally secure.

How to distinguish law, clinical standards and policy

For every requirement described as mandatory, ask the clinic to label the source: (1) Panamanian legislation or a regulation currently in force; (2) a Ministry of Health authorisation or licence condition; (3) a professional guideline; (4) a foreign rule relevant to an imported sample or contract; or (5) the clinic’s own policy. Ask for the exact document, article or clause, publication date, effective status and a short explanation of how it applies to the proposed treatment.

A clinic may apply cautious medical criteria within its governing rules and decline a case under its own protocol, but that does not turn every internal criterion into a statutory ban. Conversely, failure to locate a detailed statute does not make the procedure automatically lawful or safe. Operating authorisation, treatment legality, donor screening, informed consent, contract promises and parentage are distinct questions requiring separate evidence.

Documents to obtain before signing or paying

Before signing or paying, request a dated written pack with the clinic’s legal name and current authorisation for the proposed services; complete carrier and donor protocols; tests, timing and handling of repeat or unclear results; gamete source and traceability; and any import permit required for the sample.

Request separate consent forms for each intervention; written rules for gametes and embryos if treatment pauses, consent is withdrawn, storage expires, the clinic closes, or a participant dies or loses capacity; privacy and record-retention policies; medical-record access; and allocation of costs for extra tests, repeat screening, pregnancy complications or sample replacement.

If the clinic cites foreign law or a donor-bank standard, ask for the original source and a written explanation whether it is binding in Panama, incorporated into the contract or only internal policy. Keep the versions supplied before payment; do not rely on a brochure, chat message or verbal assurance for a decisive legal condition.

A practical decision path and warning signs

First, define the medical plan precisely: who provides the egg and sperm, whether a donor is involved, whether the carrier will also provide an egg, whether gametes or embryos cross a border, and which procedures will take place in Panama. These facts can change the analysis. Next, obtain the clinic’s protocols and exact legal citations for every claimed mandatory threshold. Confirm directly with the Ministry of Health whether the clinic authorisation and any import permission cover the planned activity and material. Have independent Panamanian counsel check the current Official Gazette, the scope of the cited rules and the legal effect of the proposed consents and agreements.

Pause if the clinic says “the law requires it” but cannot name the provision; uses a foreign donor limit without explaining its application; cannot provide a dated screening protocol; refuses to disclose which tests were done; treats consent as irrevocable without legal analysis; or claims import permission approves the whole programme. These are reasons to seek clarification, not automatic proof of misconduct. Do not ship samples, start medication, create or transfer embryos, or make an irreversible payment while a material authorisation or consent issue remains unresolved. Preserve contracts, invoices, protocols, test reports and communications.

Parentage is separate—and the next safe step

Medical eligibility and donor screening do not decide who will be recognised as a child’s legal parent. Article 243 of the Family Code provides that maternity is presumed for legal purposes when childbirth and the child’s identity are duly proved. This matters where the person giving birth and the person who supplied the egg are different, but its application to a particular case and any judicial route require separate analysis. A clinic consent form, genetic test or contract is not a guarantee that a birth-registration authority or another country will recognise the intended parents.

Before treatment, obtain advice on the carrier’s role, gamete sources, consent, foreign elements, intended birth place and later recognition. This guide covers medical and donor requirements only; it does not decide contract legality, parentage, citizenship, travel documents or recognition abroad. Resolve those issues in parallel, not after pregnancy or birth. The safest next step is a written pre-treatment review mapping each clinical criterion to a verified legal provision, licence condition, professional standard or clinic policy; confirm semen import with the Ministry; and ask local counsel to check later rules.

As of 23 October 2026. This was not a certified exhaustive search of every current Panamanian Gazette issue, administrative file or unpublished licence condition.

Sources and scope

Official legal and administrative sources are listed first. The final two items are secondary analysis, not binding law. As of 23 October 2026.

  1. S1. Código de la Familia de la República de Panamá, Ley No. 3 de 17 de mayo de 1994, arts. 235–245
  2. S2. Texto Único del Código Penal de la República de Panamá, Gaceta Oficial No. 26519 (26 April 2010), arts. 146–147
  3. S3. Decreto Ejecutivo No. 179 de 8 de junio de 2018, investigación con tejidos y células de origen humano, art. 9
  4. S4. Ley 68 de 20 de noviembre de 2003 y Decreto Ejecutivo No. 1458 de 6 de noviembre de 2012
  5. S5. Panama Digital: Autorización para la Introducción de Material Biológico de Semen Humano
  6. S8. Órgano Judicial / CENDOJ: Texto Único de la Ley N.° 14 de 2007, Código Penal actualizado a diciembre de 2020
  7. S9. Órgano Judicial / CENDOJ: official index of later Penal Code amendment laws
  8. S6. Guevara Centella, “Gestación por sustitución y la necesidad de su regulación en Panamá”, Sapientia (2021)
  9. S7. Martínez Serracín, “Surrogacy in Panama: legal foundations and guidelines for legislation that guarantees rights”, AICIS (2025)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards